Abstract

Cytomegalovirus (CMV) is one of the most commonly recognized opportunistic pathogens and remains the most influential known parameter in shaping an individual’s immune system. As such, T cells induced by CMV infection could have a long-term impact on subsequent immune responses. Accumulating evidence indicates that memory T cells developed during past bacterial and viral infection can cross-react with unrelated pathogens, including transplant antigens, and can alter responses to de novo infections, vaccines, cancers, or rejection. Therefore, careful examination of T cell responses elicited by CMV is warranted to understand their potentially beneficial or harmful roles in future major immune events. Our detailed exploration of the distribution, phenotype, TCR repertoire and transcriptome of CD4+ T cells within CMV seropositive healthy individuals using high-dimensional flow cytometry and single cell multi-omics sequencing reveals that CMV seropositivity has highly significant age-independent effects, leading to a reduction in CD4+ naïve T cells and an expansion of CD4+ effector memory T cells and CD45RA+ effector memory T cells. These induced CD4+ effector memory T cells undergo a specific differentiation trajectory resulting in a subpopulation of CD57+CD27-CD28-CD244+ CD4+ T cells with cytotoxic function and TCR oligoclonality for optimal controlled coexistence with cytomegalovirus. Through gene set enrichment analysis, we found that this subpopulation is similar to virus-specific CD8+ T cells and T cells that mediate acute rejection in patients using tacrolimus and belatacept, a selective costimulation blocker. Together, these data suggest that memory CD4+ T cells induced by cytomegalovirus are formed via a distinct differentiation program to acquire cytotoxic function and can be potentially detrimental to transplant patients adopting costimulation blockade immunosuppressive regimen.

Highlights

  • CMV reactivation or primary infection is a major source of morbidity in individuals with HIV, primary and secondary immunodeficiencies, autoimmune disease, and recipients of organ and bone marrow transplantation

  • We confirmed an enrichment of effector memory CD4+ T cells that express CD57 and CD244 but have little to no expression of CD27 or CD28. We reveal that this subset of CD4+ T cells in CMV seropositive individuals is enriched in genes associated with cytotoxicity, indicating a cytolytic, non-senescent, CMV-induced population of CD4+ T cells

  • As an initial approach to explore the heterogeneity of CD4+ T cells in CMV-infected individuals, we performed traditional user-defined sequential gating on peripheral blood mononuclear cells (PBMCs) derived from 30 CMV seropositive and 25 CMV seronegative subjects to assess the relative abundance of classically defined CD4+ T cell subsets

Read more

Summary

Introduction

CMV reactivation or primary infection is a major source of morbidity in individuals with HIV, primary and secondary immunodeficiencies, autoimmune disease, and recipients of organ and bone marrow transplantation. While the immune response to CMV has been extensively studied, our understanding of the long-term impact of CMV infection in healthy humans is incomplete. CMV specific CD4+ memory T cells are retained in large numbers and bear a similar “senescent” profile [6,7,8]. These CD4+ T cells express cytotoxic molecules typical of CD8+ T cells and NK cells [6, 9, 10]. In-depth characterization using single-cell omics of CMV-induced memory CD4+ T cell populations has yet to be done

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call